Zobrazeno 1 - 10
of 70
pro vyhledávání: '"JULIE M. PAIK"'
Autor:
Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract Background No randomized clinical trials have directly compared the cardiorenal effectiveness of empagliflozin and GLP-1RA agents with demonstrated cardioprotective effects in patients with a broad spectrum of cardiovascular risk. We reporte
Externí odkaz:
https://doaj.org/article/a409dae7b8d64bffbc67fb3a8cee406b
Autor:
Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/1b45064e466d4e25abc84ea3e931b788
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-14 (2022)
Abstract Background We conducted a systematic review and meta-analysis of the cardiovascular, kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among patients with diabetic kidney disease (DKD). Methods We searched ele
Externí odkaz:
https://doaj.org/article/6631c9bd54cc42a3bb63dba1dd7bac25
Autor:
Omar Mansour, Julie M Paik, Richard Wyss, Julianna M Mastrorilli, Lily Gui Bessette, Zhigang Lu, Theodore Tsacogianis, Kueiyu Joshua Lin
Publikováno v:
Clinical Epidemiology. 15:299-307
Omar Mansour,1,* Julie M Paik,1â 3,* Richard Wyss,1 Julianna M Mastrorilli,1 Lily Gui Bessette,1 Zhigang Lu,1 Theodore Tsacogianis,1 Kueiyu Joshua Lin1,4 1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Br
Publikováno v:
Clinical Journal of the American Society of Nephrology. 18:592-601
Publikováno v:
Current Opinion in Nephrology & Hypertension.
Autor:
Norbert Pötschke, Phyo Than Htoo, Helen Tesfaye, Julie M. Paik, Deborah Wexler, Mehdi Najafzadeh, Robert J Glynn, Anouk Déruaz-Luyet, Soulmaz Fazeli Farsani, Lisette Koeneman, Sebastian Schneeweiss, Elisabetta Patorno
Publikováno v:
Diabetologie und Stoffwechsel.
Autor:
Edouard L. Fu, Andrew S. Levey, Josef Coresh, Carl-Gustaf Elinder, Joris I. Rotmans, Friedo W. Dekker, Julie M. Paik, Peter Barany, Morgan E. Grams, Lesley A. Inker, Juan-Jesus Carrero
Publikováno v:
Journal of the American Society of Nephrology.
Autor:
Phyo T Htoo, Julie M Paik, Ethan Alt, Dae Hyun Kim, Deborah J Wexler, Seoyoung C Kim, Elisabetta Patorno
Publikováno v:
The Journals of Gerontology: Series A.
Background Severe hypoglycemia is associated with adverse clinical outcomes. We evaluated the risk of severe hypoglycemia in older adults initiating newer glucose-lowering medications overall and across strata of known indicators of high hypoglycemia
Autor:
Chelsea E. Hawley, Julie C. Lauffenburger, Julie M. Paik, Deborah J. Wexler, Seoyoung C. Kim, Elisabetta Patorno
Publikováno v:
Diabetes Care
OBJECTIVE We aimed to understand the factors associated with sodium–glucose cotransporter 2 inhibitor (SGLT2i) adherence and longitudinal adherence trajectories in older adults with type 2 diabetes. RESEARCH DESIGN AND METHODS Using Medicare claims